Objective: Atypical development, behavioral difficulties, and academic underachievement are common morbidities in children with a history of congenital heart defects and impact quality of life. Language and social-cognitive deficits have been described, which are associated with autism spectrum disorders. The current study aimed to assess the rates of autism spectrum disorders in a large sample of children with a history of congenital heart defects and to assess medical, behavioral, and individual factors that may be associated with the risk of autism spectrum disorders.
developmental challenges in this population will promote appropriate clinical care, service delivery and, hopefully, outcomes.
Multiple studies have shown that children with surgically corrected CHD demonstrate significantly more neuropsychological difficulties than typically developing children. 2, 3 Furthermore, researchers have suggested that children with CHD may be at increased risk for socialcognitive and social-communication deficits, 4 similar to those characteristic of children with autism spectrum disorders (ASDs). 5 Neufeld et al. (2008) reported that four children in their sample of 65 five-yearolds with a history of transposition of the great arteries (TGA) and an arterial switch operation met criteria for an ASD. 6 Longitudinal followup studies with individuals with a history of severe CHD suggest that issues with social cognition and self-reported ASD-associated traits continue into adolescence. 7, 8 These findings highlight the potential severity and chronicity of social issues.
Additionally, past research has highlighted the complex interplay between genetic susceptibility, medical intervention, and increasing developmental/academic expectations for children with CHD, underscoring the need to understand both the trajectory of behavioral outcomes and the contributing risk factors. 9 Neurobehavioral outcomes are likely related to a complex interaction of individual (e.g., genetic susceptibility, ethnicity, birth weight) and medical management factors. 10 Overall, the literature highlights significant interindividual variation in developmental outcomes 1 and the need for early intervention 11 and special education. 12 Therefore, an accurate assessment of the proportion of children in this population screening positive for an ASD and the factors contributing to their diagnostic status is essential to inform future research efforts and clinical management. The relationship between medical and patient factors and an ASD diagnosis may elucidate a clearer predictive relationship for social concerns.
The research questions addressed in this manuscript are as follows:
first, are children with a history of serious CHD and infant surgery at increased risk for positive results on a ASD screener relative to the general population? 13 Second, what are the relative contributions of individual/genetic, behavioral, and medical management factors to the likelihood of screening positive for an ASD? The information gained through this investigation will directly inform patient care, service delivery, and research efforts to decrease morbidity in this developmentally vulnerable population.
| M E T H O D S

| Participants
Children in the current study were participants in a large cohort with CHD previously described through longitudinal neurodevelopmental evaluations. 9 Briefly, data were collected as part of a prospective study of neurodevelopmental outcomes in children with apo-lipoprotein E 
| Measures
Measures in the current analyses included selected assessment tools from the 4-year-old neurodevelopmental evaluations and parent-report information/questionnaires from the subsequent 2010 mailing. Relevant measures are listed in The optimal SCQ cutoff to reflect parent-reported diagnosis on the health history form was determined using ROC analyses (i.e., area under the curve). The optimal cutoff for this sample is defined as the value that maximizes both sensitivity and specificity of predicting parent-reported diagnosis.
| Analytic plan: Predictive models
The stepwise variable selection method was used to create a "best prediction model" using the patient factors and behavioral data collected from the 4-year-old evaluation. All significant univariate variables were included in this selection method. Factors were identified that increased or decreased the probability of screening positive on the SCQ. A multivariable logistic regression was then used to identify the variables that accounted for the most variance in diagnostic status. Since there was some concern that some patient factors may be associated with some of the 4-year behavioral outcomes, sensitivity analyses were conducted to assess multicollinearity. While some variables were correlated with each other, multicollinearity analyses indicate that this correlation was not strong enough to affect the results of the models (i.e., variance inflation factors [VIFs] of 1.60 or less). 
| The prevalence of ASDs
A significantly higher proportion of children in this study were identified via SCQ screening and/or parent-reported diagnosis than predicted based on national rates of ASDs at the time of assessment, Ps < .05 (Table 3 ). Compared to the national rate of ASD diagnoses
(1:68; 1.47%), children with CHD screened positive for an ASD at a rate of 1:30.9 (3.2%) using conservative, established cutoffs.
| ROC analyses
The optimal cutoff value for this sample, which maximizes both sensitivity and specificity is 7 (n 5 71). Using a value of 7 as the SCQ cutoff yields a sensitivity of 0.75 and a specificity of 0.71. 
| SCQ 15
Using an SCQ cutoff score of 15, patient factors, operative management factors, and 4-year neurodevelopmental screening factors were significant predictors, Ps < .05. Univariate analyses indicated that the following variables were associated with increased risk of screening positive on the SCQ: medical/patient factors-having a possible genetic abnormality; having a confirmed genetic abnormality; having a delayed sternal closure;
behavioral factors at 4 years-having more parent-rated developmental problems; symptoms of ADHD.
The following variables were found to be associated with a decreased risk of screening positive on the SCQ: medical/patient factors -having the APOE genotype 33; older gestational age; having no genetic abnormalities; behavioral factors at 4 years-having better language skills; having better social/behavioral skills; and having a higher IQ.
Delayed sternal closure and pervasive developmental problems at 4 years (CBCL PDP) were independent predictors of diagnostic status in the univariate models. However, multivariable analysis showed that when the model was adjusted for the above predictors, only CBCL PDP was a significant predictor of diagnostic status (Table 6 ).
| SCQ cutoff 12
Analyses were then conducted using the research-supported SCQ cut- 
| SCQ cutoff 7
Logistic regression analyses were then conducted using the optimal cutoff of 7 (identified via ROC analyses), results are listed in Tables   4-6 , respectively. The multivariable analyses identified social skills at 4 years, pervasive developmental problems at 4 years, and intellectual functioning at 4 years as independent predictors and accounting for the most variance, after controlling for all other variables in the model.
| Composite variable (SCQ 12 and/or parentreported diagnosis)
Additionally, analyses were conducted using both SCQ and parent- 
| DISCUS SION
The current study found that children with a history of severe CHD requiring infant surgery are at higher risk for screening positive on a well-established ASD screener when compared to rates of ASDs in the general population. It is important to note, however, that this risk is associated with a variety of genetic, individual, operative management, and behavioral/ developmental factors. When using conservative cutoffs, delayed sternal closure and parent-reported pervasive developmental problems at 4 years of age were significantly associated with ASD-screening status. When evaluating the utility of more experimental screening cutoff points, (i.e., SCQ 7, 12, or 15) , it appears that medical variables were more predictive of ASD-screening status when using more conservative cutoff scores.
These findings are consistent with previous work showing that surgical intervention, while necessary for survival, introduces a multitude of risk factors for complicating neurobehavioral development, including preoperative and postoperative brain injury 25 and intraoperative and postoperative hemodynamic factors. 26 Timing of diagnosis has also found to be linked to developmental outcomes. 27 Unfortunately, the patient and management factors identified as predictors of risk are largely nonmodifiable.
Behavioral variables were associated with a positive ASDscreening status regardless of cutoff point. Importantly, children with more domain-general neurocognitive issues at 4 years old (e.g., cognitive, language, and attention issues) are at higher risk and need to be assessed for ASD-related issues: there may be higher false positive rates in populations with more neurodevelopmental and domaingeneral cognitive issues, highlighting the need for comprehensive ASDdiagnostic assessments to confirm current findings. Finally, although socioeconomic and cultural/racial factors were not independently associated with screening results, they are important factors to consider, particularly in light of research highlighting ethnic disparity in ASD diagnosis. 28 Taken together, these findings support that early medical factors and behavioral performance at 4 year old can help to suggest which children may be in need of additional follow-up and intervention to promote adequate neurodevelopmental progress. However, it should be emphasized that early developmental screening (beginning at 9 months) and ASD screening beginning at 18 months of age should be routine, as suggested by the American Academy of Pediatrics (AAP;
July 2006), to initiate needed interventions earlier to promote better outcomes. The current study reports on data collected at age 4 years to evaluate potential associated factors via available data, not as a suggestion that neurodevelopmental screening should begin at this age.
It is also important to highlight the utility of using lower thresholds for concern in this medically complex population. According to current results, a cutoff of 7 on the SCQ best reflected parent-reported diag- however, 12 of 13 children screening positive had a neurodevelopmental diagnosis from a community clinician (e.g., intellectual disability;
seven of which were an ASD diagnosis). 29 Furthermore, a recent study ADHD-IV Hyperactivity-Impulsivity Scale (point) showing that children with a history of CHD are at higher risk of academic, behavioral, cognitive, social, and quality-of-life challenges. 1, 9 Even within this population, Gaynor et al. (2009) previously documented that children with the APOE ¾2 allele were rated as having more impaired social skills than children with the APOE ¾4 allele. The exploratory nature of this project confers some limitations.
First, clinical diagnosis was not confirmed in this study and both diagnostic variables were provided by parent report. As with any screener, children may screen positive for other reasons (e.g., general cognitive/ language delays) and, therefore, require ASD-diagnostic clarification.
Future studies would benefit from examining factors contributing to diagnostic risk in children with clinically confirmed diagnoses of ASD.
Formal diagnostic clarification via structured parent interview and semistructured child-focused interactive measures will be important for this goal, to confirm clinical diagnoses and provide a more nuanced understanding of social cognitive and social behavioral clinical presentations.
Additionally, item-based analyses of the SCQ could be explored, to better understand specific observations bringing these children to the clinical attention of community providers. Second, the low base rate of positive ASD-screening in this sample may have limited power to detect additional relationships between variables. The low response rate of completed packets (56%) is also a limitation. Finally, inherent in the exploratory nature of this study, we chose to conduct multiple comparisons to best describe the relationship between variables. We understand that this introduces the risk of Type 1 error. Readers should interpret the precise relationships with caution and we encourage further analysis and replication to better determine how these preliminary findings fare with alternative thresholds for significance.
| CONCLUSIONS
In conclusion, although previous research has clearly described the neurodevelopmental risks for children with serious CHD requiring infant cardiac surgery, this study is the first known analysis to document the rates of positive screening for ASD specifically in a large sample, as well as the factors that may be associated with ASD risk. Rates of positive ASD-screening were higher than expected from population rates and was related to both medical/patient factors and behavioral performance at the age of 4 years. Findings highlight the need for careful, early neurodevelopmental tracking in childhood, with ASD screening beginning at 18-months of age and, for some children, referral to a specialist to assess the presence/severity of social-cognitive and communication issues. Our findings suggest that a lower threshold for screening is more applicable in this high-risk population, to ensure that children in need of services are referred to the appropriate diagnostic and therapeutic providers.
Additionally, our findings show that screening results do not always match with clinical diagnoses, which emphasizes the need for comprehensive clinical assessment of ASDs and other developmental disorders.
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